Role of TFRC as a Novel Prognostic Biomarker and in Immunotherapy for Pancreatic Carcinoma

Role of TFRC as a Novel Prognostic Biomarker and in Immunotherapy for Pancreatic Carcinoma

Objective: To explore the expression of the transferrin receptor (TFRC) gene in pancreatic cancer and to analyze the pathogenesis and immunotherapy of TFRC in patients using bioinformatics methods.Methods: We used public data from the cancer genome atlas (TCGA) and gene expression omnibus databases...

Full description

Bibliographic Details
Main Authors: Cheng Yang, Junqiang Li, Yongdong Guo, Dongxue Gan, Chao Zhang, Ronglin Wang, Lei Hua, Liaoliao Zhu, Peixiang Ma, Jingjie Shi, Shanshan Li, Haichuan Su
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-03-01
Series:Frontiers in Molecular Biosciences
Subjects:
TFRC
pancreatic cancer
bioinformatics
immunotherapy
CAR- T cells
Online Access:https://www.frontiersin.org/articles/10.3389/fmolb.2022.756895/full

Internet

https://www.frontiersin.org/articles/10.3389/fmolb.2022.756895/full

Similar Items